Table 4.
Baseline | 3 months | 6 months | Yearly | |
---|---|---|---|---|
Symptom evaluation | × | × | × | × |
Adverse event monitoring | × | × | × | |
Serum testosterone | × | × | × | × |
Hematocrit | × | × | × | |
Prostate-specific antigen (PSA) | × | × | × | × |
Digital rectal examination (DRE) | × | × |